As of January 2021, there are two COVID-19 vaccines that have been approved by the Federal Drug Administration (FDA) for use in the United States
Read More >
Peripheral T-cell lymphoma (PTCL) is an aggressive (fast-growing) form of non-Hodgkin lymphoma which has typically been associated with having no standard of care. For most
Read More >
U.S. Food and Drug Administration (FDA) approved the first biomarker-driven therapy for pediatric ALCL.
Read More >
Checkpoint inhibitors are a new class of drugs used by the immune system to determine whether or not to launch an immune response. By activating
Read More >
A lymphoma diagnosis can be challenging to cope with at any time, but the current pandemic has only increased stress, anxiety, and depression for many
Read More >
